GlobeNewswire

YouVersion Bible App celebrates 10th anniversary

Dela

Most downloaded Bible app helps change Bible engagement worldwide

 

OKLAHOMA CITY, July 09, 2018 (GLOBE NEWSWIRE) -- This July, YouVersion celebrates the 10-year anniversary of the Bible App, which was one of the first 200 free apps available when Apple launched the App Store on July 10, 2008. In the decade since, the Bible App has been downloaded on more than 330 million devices and in every country of the world.

"We never could have predicted the results we've seen as millions of people around the world have read, listened to, shared, and interacted with the Bible and each other in new ways," said Bobby Gruenewald, Life.Church Pastor, Innovation Leader and YouVersion Founder.

After seeing 83,000 installs of the Bible App in the first three days, it went on to reach 10 million installs in 2010, 50 million installs in 2012, and 100 million installs in 2013. In the last decade, people have used the Bible App to: 

  • Read 70 billion chapters of the Bible 
  • Listen to 12 billion audio chapters of the Bible
  • Make 4 billion Highlights, Bookmarks, and Notes 
  • Complete 2.4 billion Bible Plan days 

"Early on, we discovered that proximity helped us engage with the Bible," said Gruenewald. "As soon as I had access to the Bible on the phone that's always in my pocket, my connection to it naturally became more frequent."

As the Bible App grew, users cited the ability to quickly switch between different versions of the Bible as a favorite feature. The app, which initially launched with 15 versions and two languages, has since partnered with publishers and Bible societies to offer more than 1,700 different versions of the Bible, including Bible text in more than 1,200 languages. 

With smartphones propelling social media platforms to new heights, the YouVersion community quickly adopted social sharing features as they were added to the app. Over the last decade, Bible App users have shared more than 950 million Bible verses, earning the Bible a prominent place in people's lives and social media feeds.

Recognizing the opportunity to bring more relational interaction around the Bible, YouVersion introduced community features such as a home feed of friends' activity and the ability to study the Bible together. Through Plans with Friends, people can connect and discuss the Bible when they aren't in the same room, or even the same country. This feature helped change the life of a New Jersey native, Adora, who used the Bible App to rebuild a relationship with her mother.

"When I started using the Bible App, I hadn't seen or spoken to my mother in 10 years," said Adora. "After several months of reading Bible Plans about forgiveness and healing, I decided to offer my mom a relationship with me-but only in the Bible App."

Adora added her mother as a Friend in the Bible App and sent an invitation to do a Bible Plan together using the Plans with Friends feature. As they talked about what they were reading, they opened up about mutual feelings of hurt and anger. They slowly went from only talking in the Bible App, to texting, and then meeting in person to pray.

"I never, ever thought that I would have a relationship with my mom again," said Adora. "But by reading the Bible and doing these daily plans, God has worked a miracle on my heart and in my life."

Beyond shaping the way we interact with Scripture and each other, the Bible App has introduced a way for the Bible to reach us in our everyday lives. Features like Verse of the Day notifications, reading reminders, and daily Streaks have helped people develop new Bible-reading habits, sometimes after years of trying to do so on their own.

"When people install the Bible App, it's usually because they want to read it more. So we've spent a lot of time thinking about how to help them do what they want to do," said Gruenewald. 

Each new feature is targeted to increase daily engagement from the YouVersion community. Since adding features like daily Streaks and Perfect Weeks, the number of daily active users has increased by more than 30 percent compared to last year.

"These last 10 years have been more than we could ask, think, or imagine, and we believe this is only the beginning," said Gruenewald. "As we look ahead, we're excited about the new ways God is using technology to help people make even more connections between the Bible and their daily lives."

YouVersion will soon launch Bible Lens, a new app that analyzes the objects in a photo and detects biblical themes to suggest the Bible verse that best fits the photo. Then, it automatically designs a high-quality Verse Image that can be shared with friends. Additionally, the app will have the ability to create Verse Images from photos saved in a person's camera roll to help them rediscover every moment of their life through the lens of the Bible.

Visit blog.youversion.com to stay updated on YouVersion and its products.

About YouVersion             
YouVersion was created by Life.Church to help people engage with the Bible. The team designs and builds experiences that make it easy for people to integrate the Bible into their everyday lives. Since 2008, the Bible App has offered a free Bible experience on smartphones, tablets, and computers that allows people to read the Bible at any time and in any place. In 2013, YouVersion launched the Bible App for Kids, in partnership with OneHope, to engage children with beautifully illustrated, interactive Bible adventures. For more information about YouVersion, visit www.youversion.com.

Rachel Feuerborn 
405-216-7072 
press@youversion.com

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/f30266ec-0b9d-4f60-ab42-9873bd1a7cdc

http://www.globenewswire.com/NewsRoom/AttachmentNg/463935be-157a-4c29-ba41-d011cdd62e3d




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: YouVersion via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Oboya participates in China International Import Expo1.11.2018 15:00Pressmeddelande

Newsletter Lerum, 1th November 2018 Oboya Horticulture Industries AB (publ) ("Oboya"), a global manufacturer and supplier of products and services for the cultivation industry, will participate in China International Import Expo in Shanghai, China. China International Import Expo (CIIE) is a six-day fair held from November 5 to November 10, 2018 at the National Convention & Exhibition Center in Shanghai, China. This fair brings together companies, exhibitors and professional buyers from all over the world. The fair creates new channels for companies from different countries and regions and provides the opportunity to do business, strengthen cooperation and promote trade. Oboya's strategy is to work globally in the various markets in the cultivation and flower industry, which it's important for Oboya to participate in the major trade shows. Oboya has its own booth at the fair and will show/marketing the European cultivation products and technology to the Chinese market. The purpose of t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum